About
Patrick Trojer, PhD, is a biotech executive and scientist serving as President and CEO of TRIANA Biomedicines since November 2021. He previously co-founded Constellation Pharmaceuticals in 2008 and rose through research leadership roles to become Chief Scientific Officer; public sources also list him as a Raven Advisor with RA Capital and Chair of the Board of Booster Therapeutics.
Areas of interest
biotechoncologydrug discoverymolecular gluestargeted protein degradationepigeneticschromatin biologytranslational scienceneurodegeneration